Endoplasmic reticulum-stress and unfolded protein response-activation in immune-mediated necrotizing myopathy.
ER-stress
HMGCR
IMNM
SRP
UPR
auto-antibodies
Journal
Brain pathology (Zurich, Switzerland)
ISSN: 1750-3639
Titre abrégé: Brain Pathol
Pays: Switzerland
ID NLM: 9216781
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
02
09
2021
accepted:
12
05
2022
pubmed:
16
6
2022
medline:
2
11
2022
entrez:
15
6
2022
Statut:
ppublish
Résumé
Patients suffering from immune-mediated necrotizing myopathies (IMNM) harbor, the pathognomonic myositis-specific auto-antibodies anti-SRP54 or -HMGCR, while about one third of them do not. Activation of chaperone-assisted autophagy was described as being part of the molecular etiology of IMNM. Endoplasmic reticulum (ER)/sarcoplasmic reticulum (SR)-stress accompanied by activation of the unfolded protein response (UPR) often precedes activation of the protein clearance machinery and represents a cellular defense mechanism toward restoration of proteostasis. Here, we show that ER/SR-stress may be part of the molecular etiology of IMNM. To address this assumption, ER/SR-stress related key players covering the three known branches (PERK-mediated, IRE1-mediated, and ATF6-mediated) were investigated on both, the transcript and the protein levels utilizing 39 muscle biopsy specimens derived from IMNM-patients. Our results demonstrate an activation of all three UPR-branches in IMNM, which most likely precedes the activation of the protein clearance machinery. In detail, we identified increased phosphorylation of PERK and eIF2a along with increased expression and protein abundance of ATF4, all well-documented characteristics for the activation of the UPR. Further, we identified increased general XBP1-level, and elevated XBP1 protein levels. Additionally, our transcript studies revealed an increased ATF6-expression, which was confirmed by immunostaining studies indicating a myonuclear translocation of the cleaved ATF6-form toward the forced transcription of UPR-related chaperones. In accordance with that, our data demonstrate an increase of downstream factors including ER/SR co-chaperones and chaperones (e.g., SIL1) indicating an UPR-activation on a broader level with no significant differences between seropositive and seronegative patients. Taken together, one might assume that UPR-activation within muscle fibers might not only serve to restore protein homeostasis, but also enhance sarcolemmal presentation of proteins crucial for attracting immune cells. Since modulation of ER-stress and UPR via application of chemical chaperones became a promising therapeutic treatment approach, our findings might represent the starting point for new interventional concepts.
Identifiants
pubmed: 35703068
doi: 10.1111/bpa.13084
pmc: PMC9616093
doi:
Substances chimiques
eIF-2 Kinase
EC 2.7.11.1
Protein Serine-Threonine Kinases
EC 2.7.11.1
Molecular Chaperones
0
SIL1 protein, human
0
Guanine Nucleotide Exchange Factors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13084Informations de copyright
© 2022 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.
Références
Nat Neurosci. 2015 Feb;18(2):227-38
pubmed: 25559081
Int Rev Cell Mol Biol. 2013;301:215-90
pubmed: 23317820
Neuropathol Appl Neurobiol. 2017 Feb;43(1):62-81
pubmed: 28075491
Brain Pathol. 2022 Nov;32(6):e13084
pubmed: 35703068
Mol Neurobiol. 2018 Mar;55(3):2524-2546
pubmed: 28401474
Neuromuscul Disord. 2018 Dec;28(12):1022-1030
pubmed: 30424919
PLoS One. 2012;7(6):e38011
pubmed: 22723842
Neuromuscul Disord. 2018 Jan;28(1):87-99
pubmed: 29221629
Neurol Neuroimmunol Neuroinflamm. 2019 Apr 10;6(3):e558
pubmed: 31044146
Science. 2011 Nov 25;334(6059):1081-6
pubmed: 22116877
J Cell Physiol. 2018 May;233(5):3867-3874
pubmed: 28777470
Neuromuscul Disord. 2015 Mar;25(3):268-72
pubmed: 25572016
Nat Immunol. 2022 Mar;23(3):431-445
pubmed: 35228694
Proteomics. 2011 Mar;11(5):996-9
pubmed: 21337703
Sci Rep. 2020 Jul 28;10(1):12620
pubmed: 32724133
Microsc Microanal. 2021 Aug;27(4):815-827
pubmed: 34266508
Redox Biol. 2019 Sep;26:101232
pubmed: 31181458
Nat Biotechnol. 2015 Jan;33(1):22-4
pubmed: 25574629
Biochim Biophys Acta. 2015 Apr;1852(4):633-43
pubmed: 25241263
Acta Neuropathol Commun. 2016 Apr 27;4(1):45
pubmed: 27121733
Brain Pathol. 2020 Mar;30(2):261-271
pubmed: 31376301
Autophagy. 2008 Feb;4(2):257-60
pubmed: 17986849
Methods Mol Biol. 2020;2169:197-216
pubmed: 32548831
Cell Mol Life Sci. 2009 May;66(9):1556-69
pubmed: 19151922
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Biology (Basel). 2021 Apr 29;10(5):
pubmed: 33946669
Acta Neuropathol. 2014 May;127(5):761-77
pubmed: 24362440
Thorax. 2021 Jan;76(1):92-99
pubmed: 33077618
J Proteomics. 2012 Feb 2;75(4):1454-62
pubmed: 22166745
Nat Cell Biol. 2000 Jun;2(6):326-32
pubmed: 10854322
Nat Struct Mol Biol. 2019 Nov;26(11):1053-1062
pubmed: 31695187
Autophagy. 2005 Apr;1(1):1-10
pubmed: 16874026
Sci Rep. 2017 Feb 08;7:42162
pubmed: 28176833
Exp Oncol. 2012 Oct;34(3):286-97
pubmed: 23070014